Comparative in-vitro activity of cefdinir against multiresistant Haemophilus influenzae.
Department of Microbiology, University of Sevilla Medical School, Spain.
E J
EJ
Perea
M C
MC
Garcia Iglesias
D000658:Amoxicillin / Q000494:pharmacology; D019980:Amoxicillin-Potassium Clavulanate Combination; D000668:Ampicillin Resistance; D002433:Cefaclor / Q000494:pharmacology; D000077525:Cefdinir; D020682:Cefixime; D002439:Cefotaxime / Q000031:analogs & derivatives / Q000494:pharmacology; D002444:Cefuroxime / Q000494:pharmacology; D002511:Cephalosporins / Q000494:pharmacology*; D002969:Clavulanic Acids / Q000494:pharmacology; D018432:Drug Resistance, Multiple; D006193:Haemophilus influenzae / Q000187:drug effects* / Q000201:enzymology; D007700:Kinetics; D008826:Microbial Sensitivity Tests; D001618:beta-Lactamases / Q000096:biosynthesis
D002511:Cephalosporins; D002969:Clavulanic Acids; D002433:Cefaclor; D019980:Amoxicillin-Potassium Clavulanate Combination; D000658:Amoxicillin; D020682:Cefixime; D000077525:Cefdinir; D001618:beta-Lactamases; D002439:Cefotaxime; D002444:Cefuroxime